BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 8918537)

  • 1. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
    Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
    Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
    Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.
    Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH
    Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7.
    Lazdins I; Coulson BS; Kirkwood C; Dyall-Smith M; Masendycz PJ; Sonza S; Holmes IH
    Virology; 1995 May; 209(1):80-9. PubMed ID: 7747487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions.
    Dunn SJ; Ward RL; McNeal MM; Cross TL; Greenberg HB
    Virology; 1993 Nov; 197(1):397-404. PubMed ID: 7692670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure.
    Zhou YJ; Burns JW; Morita Y; Tanaka T; Estes MK
    J Virol; 1994 Jun; 68(6):3955-64. PubMed ID: 7514681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a new VP4 serotype of human rotaviruses.
    Gerna G; Sears J; Hoshino Y; Steele AD; Nakagomi O; Sarasini A; Flores J
    Virology; 1994 Apr; 200(1):66-71. PubMed ID: 8128639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neutralizing monoclonal antibody to bovine rotavirus VP8 neutralizes rotavirus infection without inhibiting virus attachment to MA-104 cells.
    Lee J; Babiuk LA; Yoo D
    Can J Vet Res; 1998 Jan; 62(1):63-7. PubMed ID: 9442942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of VP4 of G serotype 10 rotavirus (B223) in the induction of the heterologous immune response in calves.
    Xu Z; Woode GN
    Virology; 1993 Sep; 196(1):294-7. PubMed ID: 8395118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus.
    Fiore L; Dunn SJ; Ridolfi B; Ruggeri FM; Mackow ER; Greenberg HB
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1981-8. PubMed ID: 7636478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Knowlton DR; McNeal MM; Ward RL
    Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of VP4 and VP7 of five murine rotavirus strains.
    Dunn SJ; Burns JW; Cross TL; Vo PT; Ward RL; Bremont M; Greenberg HB
    Virology; 1994 Sep; 203(2):250-9. PubMed ID: 8053149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
    Ruggeri FM; Greenberg HB
    J Virol; 1991 May; 65(5):2211-9. PubMed ID: 1850007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of neutralization epitopes on the VP7 surface protein of serotype G11 porcine rotaviruses.
    Ciarlet M; Hidalgo M; Gorziglia M; Liprandi F
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1867-73. PubMed ID: 7519247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the newly identified neutralization epitopes on VP7 of human rotavirus serotype 1.
    Kobayashi N; Taniguchi K; Urasawa S
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():117-24. PubMed ID: 1703558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotaviruses.
    Kirkwood C; Masendycz PJ; Coulson BS
    Virology; 1993 Sep; 196(1):79-88. PubMed ID: 8395127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA immunization with a bovine rotavirus VP4 gene induces a Th1-like immune response in mice.
    Suradhat S; Yoo D; Babiuk LA; Griebel P; Baca-Estrada ME
    Viral Immunol; 1997; 10(3):117-27. PubMed ID: 9344334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of antigenic sites involved in serotype-cross-reactive neutralization on group A rotavirus outercapsid glycoprotein VP7.
    Hoshino Y; Nishikawa K; Benfield DA; Gorziglia M
    Virology; 1994 Feb; 199(1):233-7. PubMed ID: 8116249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a neutralizing epitope on an 82-kDa protein encoded by gene 3 of group C rotavirus.
    Nilsson M; Svensson L
    Virology; 1995 Apr; 208(1):354-8. PubMed ID: 11831719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.